Cortagen
CognitiveKhavinson cortical bioregulator / researchExperimental
Short peptide marketed as a cerebral-cortex bioregulator. Not FDA-approved.
For research use only.
Key Facts
- CAS
- —
- Molecular Weight (MW)
- —
- Half-life
- —
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- —
- Last updated
- 8/23/2026
- Targets
- Cortical neurons (proposed)
Overview
Short peptide marketed as a cerebral-cortex bioregulator. Not FDA-approved.
Protocol
- Dosage Range
- Vendor research protocols only
- Frequency
- —
- Cycle
- —
- Administration Route
- Subcutaneous
- Reconstitution Guide
- —
Science
Mechanism of Action
Proposed cortical-neuron gene modulation in older papers.
Targets
Cortical neurons (proposed)
Studies
- Khavinson bioregulators— Journal/year not available
Benefits
Historical nootropic-bioregulator category
Potential Side Effects
- Not characterized
References
- PMID 15587334External link · Year —